U.S. Markets close in 3 hrs 51 mins
  • S&P 500

    4,402.71
    +48.52 (+1.11%)
     
  • Dow 30

    34,336.40
    +416.56 (+1.23%)
     
  • Nasdaq

    14,894.65
    +148.26 (+1.01%)
     
  • Russell 2000

    2,222.85
    +36.66 (+1.68%)
     
  • Crude Oil

    70.51
    -0.05 (-0.07%)
     
  • Gold

    1,779.40
    +1.20 (+0.07%)
     
  • Silver

    22.80
    +0.23 (+1.01%)
     
  • EUR/USD

    1.1744
    +0.0014 (+0.1174%)
     
  • 10-Yr Bond

    1.3110
    -0.0130 (-0.98%)
     
  • Vix

    21.42
    -2.94 (-12.07%)
     
  • GBP/USD

    1.3667
    +0.0003 (+0.0232%)
     
  • USD/JPY

    109.6070
    +0.3870 (+0.3543%)
     
  • BTC-USD

    44,590.88
    -3,435.44 (-7.15%)
     
  • CMC Crypto 200

    1,080.31
    +39.83 (+3.83%)
     
  • FTSE 100

    7,083.37
    +102.39 (+1.47%)
     
  • Nikkei 225

    29,639.40
    -200.31 (-0.67%)
     

3 COVID Stocks That Might Double Soon

·6 min read
3 COVID Stocks That Might Double Soon
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Read more to find out why we think Novavax (NASDAQ: NVAX), Sorrento Therapeutics (NASDAQ: SRNE), and InMode (NASDAQ: INMD) will close out 2021 with a bang. Taylor Carmichael (Novavax): Novavax stock has already doubled this year, running from $112 back in January to $233 this week. Right now, Moderna enjoys a $169 billion market cap, and BioNTech sports a $79 billion valuation.